Keyphrases
Adverse Drug Events
90%
Psoriasis
52%
Randomized Controlled Trial
42%
Melanoma
38%
Quality of Life
35%
Thalidomide
35%
In Cancer
31%
Cancer Patients
31%
Adverse Events
30%
Acne
30%
Alopecia Areata
29%
Clinical Trials
29%
Adverse Event Reporting System
29%
Randomized Clinical Trial
28%
Topical Minoxidil
26%
Hair Regrowth
24%
Epidermal Growth Factor Receptor Inhibitors
24%
Minoxidil
24%
Dermatological Adverse Effects
23%
Institutional Review Board
20%
Tongue Drive System
20%
Cancer-related
20%
Dermatologist
19%
Confidence Interval
19%
Atopic Dermatitis
19%
Erythema
19%
Rash
18%
Facial Skin
18%
Pediatric
18%
Adverse Drug Reaction
18%
Non-melanoma Skin Cancer
17%
Human Keratinocytes (HaCaT)
17%
Nephrogenic Systemic Fibrosis
17%
Biological Agents
17%
Odds Ratio
17%
Keratinocyte Proliferation
17%
Mohs Micrographic Surgery
17%
Scabies
17%
Videodermoscopy
17%
Programming Languages
17%
Cutaneous Reaction
17%
Dapsone
16%
Bisphosphonates
16%
Metastatic Melanoma
15%
Patients with Cancer
15%
Serious Adverse Events
15%
Dermatologic Toxicity
15%
Gadolinium-based Contrast Agents
15%
Cancer Drugs
15%
Single Center
14%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Drug Reaction
100%
Malignant Neoplasm
98%
Adverse Event
88%
Dermatological Agent
39%
Psoriasis
37%
Minoxidil
34%
Clinical Trial
33%
Acne
27%
Diseases
25%
Alopecia Areata
24%
Rash
23%
Thalidomide
23%
Epidermal Growth Factor Receptor Kinase Inhibitor
22%
Pharmacovigilance
21%
Melanoma
21%
Bisphosphonic Acid Derivative
21%
Infection
19%
Skin Toxicity
19%
Biological Product
18%
Randomized Controlled Trial
17%
Non Melanoma Skin Cancer
15%
Skin Manifestation
15%
Alopecia
14%
Contrast Medium
14%
Gadolinium
14%
Side Effect
14%
Tumor Necrosis Factor Inhibitor
13%
Pharmacotherapy
13%
Femur Fracture
12%
Nephrogenic Systemic Fibrosis
12%
Irritant Dermatitis
12%
Erythema
12%
Cohort Study
12%
Breast Cancer
12%
Sunitinib
11%
Wound
11%
Atopic Dermatitis
11%
Antianemic Agent
11%
Etretinate
11%
Finasteride
11%
Anaphylaxis
11%
Angiotensin Receptor Antagonist
11%
Methotrexate
11%
Stevens Johnson Syndrome
11%
Hepatotoxicity
11%
Acne Vulgaris
11%
Capsaicin
11%
FDA Adverse Event Reporting System
10%
Dry Skin
10%
Pruritus
10%
Medicine and Dentistry
Adverse Event
60%
Melanoma
50%
Dermatological Agent
46%
Randomized Controlled Trial
46%
Psoriasis
37%
Quality of Life
32%
Diseases
31%
Malignant Neoplasm
30%
Randomized Clinical Trial
28%
Infection
25%
Adverse Drug Reaction
23%
Acneiform Eruption
23%
Pediatrics
22%
Skin Manifestation
20%
Dermatology
19%
Epidermal Growth Factor Receptor Kinase Inhibitor
18%
Alopecia Areata
17%
Tongue
17%
Scabies
17%
Prospective Cohort Study
17%
Bisphosphonate
17%
Arm
16%
Disease
16%
Non Melanoma Skin Cancer
15%
Odds Ratio
14%
Facial Skin
14%
Contralateral
13%
Side Effect
13%
Biological Product
13%
Erythema
12%
Nephrogenic Systemic Fibrosis
12%
Health Care Cost
12%
Pediculosis
11%
Lupus Erythematosus Panniculitis
11%
Mohs Surgery
11%
Tetraplegia
11%
Systematic Review
11%
Etretinate
11%
Minoxidil
11%
Thrombocyte Rich Plasma
11%
Angiotensin Receptor Antagonist
11%
Biological Therapy
11%
Skin Toxicity
11%
Acne Vulgaris
11%
Case-Control Study
11%
Table Salt
11%
Exanthem
11%
Neoplasm
11%
Hyperpigmentation
10%
Cheek
10%